Algorithms for improving pharmaceutical care when using a group of antipsychotic drugs

Abstract

At the present stage, sections and separate points of pharmaceutical care for patients and patients with neuropsychiatric pathology who use antipsychotic drugs of the psycholeptic group have been substantiated and improved. The necessity of an integrated approach to the clinical problem of treatment of crisis states has been identified and proved. Clinical and pharmaceutical substantiation and improvement of modern aspects of pharmaceutical care in the use of a group of antipsychotic drugs contributes to the improvement of the level of professional training of doctors, pharmacists and clinical pharmacists.